WallStreetZenWallStreetZen

NASDAQ: ORMP
Oramed Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ORMP stock forecasts and price targets.

Forecast return on equity

Is ORMP forecast to generate an efficient return?

Company
30.87%
Industry
-24.96%
Market
136.07%
ORMP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ORMP forecast to generate an efficient return on assets?

Company
26.52%
Industry
-15.44%
ORMP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ORMP earnings per share forecast

What is ORMP's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$2.36-44.3%

ORMP revenue forecast

What is ORMP's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0

ORMP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ORMP$4.81N/AN/A
CRBP$10.38$37.50+261.27%Strong Buy
NGEN$1.86$12.50+572.04%Buy
KRRO$13.18$20.25+53.64%Strong Buy
PLX$2.38$12.00+404.20%Buy
View Top Biotech Stocks

Oramed Pharmaceuticals Stock Forecast FAQ

What is ORMP's earnings growth forecast for 2026-2026?

(NASDAQ: ORMP) Oramed Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Oramed Pharmaceuticals's earnings in 2026 is $174,870,000.

In 2026, ORMP is forecast to generate $98,011,685 in earnings, with the lowest earnings forecast at $94,168,090 and the highest earnings forecast at $100,894,382.

If you're new to stock investing, here's how to buy Oramed Pharmaceuticals stock.

What is ORMP's revenue growth forecast for 2026-2026?

(NASDAQ: ORMP) Oramed Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Oramed Pharmaceuticals's revenue in 2026 is $0.

In 2026, ORMP is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is ORMP's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: ORMP) forecast ROA is 26.52%, which is higher than the forecast US Biotechnology industry average of -15.44%.

What is ORMP's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: ORMP) Oramed Pharmaceuticals's current Earnings Per Share (EPS) is $4.23. In 2026, ORMP's EPS is forecast to hit $2.36 (min: $2.26, max: $2.43).

What is ORMP's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: ORMP) forecast ROE is 30.87%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.